采用差示扫描量热分析筛选与白障明无相互作用的辅料、片剂处方组成与工艺，改善了白障明的吸湿性。白障明片20min累积溶出度为98．84％±0．64％。白障明与白障明片用热重分析法分别测得热解活化能Ea为116±13kJ／mol与126±7kJ／mol，两者无显著性差异。在37℃、RH75％放置3个月，外观与含量等无变化。

Differential scanning colorimetry(DSC) was used to screen out best excipientswhich do not interact with bendazac lysine(BZL).According to the preformulation studies,for-mulation composition and preparation of ordinary tablets have been designed. The humidificationof BZL was improved. The cumulative dissolution in 20min of the tablets was 98. 84%±0. 64%.Using thermogravimetry analysis(TGA ) method the activation energies of thermal degradationwere found to be 116±13(BZL) and 126±7(tablets)kJ/mol,respectively,which are not obviously different.On the other hand,the appearance and the content of the tablets had no change after three months of storage at 37℃ and 75% RH.